Valproate - direct healthcare professional communication (DHPC)

DHPCHuman

Polish is available via eTranslation, the European Commission's machine translation service.

Translate to Polish | Important information about machine translation

O stronie

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Dokumenty

Direct healthcare professional communication (DHPC) : Valproate-containing medicines - new measures regarding the potential risk of neurodevelopmental disorders in children of fathers treated with valproate in the 3 months prior to conception

English (EN) (253.94 KB - PDF)

Opublikowane po raz pierwszy:
Zobacz

Key facts

Active substance
valproate
Therapeutic area (MeSH)
  • Epilepsy
  • Bipolar Disorder
  • Migraine Disorders
Procedure number
EMEA/H/N/PSR/J/0043
Regulatory outcome
Variation
DHPC type
Post-authorisation measure
Human ATC codes
N03AG01
Dissemination date

Share this page